Correlation Between Shattuck Labs and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shattuck Labs and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shattuck Labs and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shattuck Labs and Vincerx Pharma, you can compare the effects of market volatilities on Shattuck Labs and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shattuck Labs with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shattuck Labs and Vincerx Pharma.

Diversification Opportunities for Shattuck Labs and Vincerx Pharma

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Shattuck and Vincerx is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Shattuck Labs and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Shattuck Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shattuck Labs are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Shattuck Labs i.e., Shattuck Labs and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Shattuck Labs and Vincerx Pharma

Given the investment horizon of 90 days Shattuck Labs is expected to generate 1.38 times more return on investment than Vincerx Pharma. However, Shattuck Labs is 1.38 times more volatile than Vincerx Pharma. It trades about -0.2 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.47 per unit of risk. If you would invest  131.00  in Shattuck Labs on August 26, 2024 and sell it today you would lose (31.00) from holding Shattuck Labs or give up 23.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Shattuck Labs  vs.  Vincerx Pharma

 Performance 
       Timeline  
Shattuck Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shattuck Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Shattuck Labs and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shattuck Labs and Vincerx Pharma

The main advantage of trading using opposite Shattuck Labs and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shattuck Labs position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind Shattuck Labs and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios